Testosterone Treatment Trials Deliver “Mixed Results.”

reports the latest clinical trials of testosterone treatment have “reported mixed results.” Studies found the treatment helped improve anemia and low bone density, but had no effect on cognitive function. However, they did find it cause a “greater buildup of noncalcified plaque in the coronary arteries,” a “red flag” for heart problems. The times notes that the “Food and Drug Administration already requires testosterone products to carry warnings of an increased risk of heart attacks and stroke.” However, Dr. Evan Hadley, director of the division of geriatrics and clinical gerontology at the National Institute on Aging, noted that the trials “didn’t answer the question of risk,” adding, “It’s very important to get definitive data on risk so we have the whole picture of risk and benefit.” https://www.nytimes.com/2017/03/28/well/testosterone-therapy-is-popular-but-studies-are-mixed.html